ScRA1 mRNA in macrophages exposed to 10% plasma obtained from SLE subjects post-placebo treatment and 10% plasma obtained from SLE subjects post-atorvastatin-treatment showed no change at 0.84 (95% CI (0.46 to 1.54)) and 0.90 (95% CI (0.42 to 1.91), Finteraction (1, 32) = 0.062, p = 0.81; Figure 4) compared to cells exposed to respective pre-treatment plasma set at 1.0. Here, MNX1 is linked to systemic lupus erythematosus.